Mikkilineni et al., in a retrospective analysis of 162 children and adults with a variety of malignancies treated with CAR T-cells directed against a variety of targets (CD19, CD22, GD2, BCMA), also identified those with multiple myeloma as the group with the highest risk for infection (15). The gene discussed is TNFRSF17; the disease is infection.